Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pelthos Therapeutics (PTHS) Return on Sales (2024 - 2025)

Pelthos Therapeutics has reported Return on Sales over the past 2 years, most recently at 1.31% for Q4 2025.

  • Quarterly results put Return on Sales at 1.31% for Q4 2025, down 546.0% from a year ago — trailing twelve months through Dec 2025 was 1.81% (down 7612.0% YoY), and the annual figure for FY2025 was 2.58%, changed.
  • Return on Sales for Q4 2025 was 1.31% at Pelthos Therapeutics, up from 2.19% in the prior quarter.
  • Over the last five years, Return on Sales for PTHS hit a ceiling of 1217.85% in Q2 2025 and a floor of 502.3% in Q2 2024.